Recent Patents on AntiCancer Drug Discovery
Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
FOR REVIEWERS
CONTENTS & ABSTRACTS
CONTACT US
Sunday, May 28, 2017
Free Trial Request
10:16 PM
No comments
Free Trial Request
Read More
Monday, May 22, 2017
Most Accessed Article: HSP90 Inhibitors:Current Development and Potential in Cancer Therapy
10:56 PM
No comments
Most Accessed Article: HSP90 Inhibitors:Current Development and Potential in Cancer Therapy
Read More
Tuesday, May 9, 2017
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
3:28 AM
No comments
Open Access Article: Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens
Read More
Newer Posts
Older Posts
Home
Social Profiles
Popular
Tags
Blog Archives
Highlighted Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conse...
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 13 Issue 1
Call For Paper
Call For Paper
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
New Issue Published Recent Patents on Anti-Cancer Drug Discovery Vol. 12 Issue 3.
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Author(s): Zsuzsanna SubaPages 154-167 (14) Abstract: Literary data suggest apparently ambiguous interaction between menopausal status...
Open Access Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Open Access Article: Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Couple...
Highlighted Article: Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Highlighted Article: Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Author(s): Zsuzsanna SubaPages 1-13 (13) Abstract: Background. Results of long-term studies justify that the rate of breast cancer rec...
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Author(s): Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu and Dixian LuoPages 184-196 (13) Abst...
New Issue::: Recent Patents on Anti-Cancer Drug Discovery, 11 Issue 1
Recent Patents on Anti-Cancer Drug Discovery publishes review and research articles, and guest edited thematic issues on recent patents ...
Blog Archive
►
2018
(1)
►
January
(1)
▼
2017
(34)
►
November
(1)
►
October
(3)
►
September
(2)
►
August
(3)
►
July
(4)
►
June
(3)
▼
May
(3)
Free Trial Request
Most Accessed Article: HSP90 Inhibitors:Current De...
Open Access Article: Activating Mutations of ESR1,...
►
April
(3)
►
March
(4)
►
February
(2)
►
January
(6)
►
2016
(22)
►
December
(5)
►
November
(5)
►
October
(7)
►
August
(1)
►
June
(4)
Blogger templates
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion